Published in Biol Pharm Bull on December 01, 1995
p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol (2009) 1.36
Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate. Eur J Drug Metab Pharmacokinet (2002) 0.94
Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin. Clin Exp Nephrol (2013) 0.83
Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS. Mass Spectrom (Tokyo) (2013) 0.80
Binding affinity and capacity for the uremic toxin indoxyl sulfate. Toxins (Basel) (2014) 0.79
Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study. Sci Rep (2016) 0.77
Crystallographic analysis reveals the structural basis of the high-affinity binding of iophenoxic acid to human serum albumin. BMC Struct Biol (2011) 0.77
Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidative stress-mediated expression of myostatin and atrogin-1. Sci Rep (2016) 0.75
Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia. Clin Chem (1997) 1.47
Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem (1999) 1.39
Cyclodextrins in drug carrier systems. Crit Rev Ther Drug Carrier Syst (1987) 1.33
The controlled release of prednisolone using alginate gel. Pharm Res (1994) 1.29
Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. J Pharmacobiodyn (1982) 1.11
Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity. Biochem J (2000) 1.10
Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. J Pharm Sci (1997) 1.08
Species differences of serum albumins: I. Drug binding sites. Pharm Res (1997) 1.06
Characterization of site I on human serum albumin: concept about the structure of a drug binding site. Biochim Biophys Acta (1996) 1.04
Probing the cysteine 34 residue in human serum albumin using fluorescence techniques. Biochim Biophys Acta (1997) 1.04
Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin. Biol Pharm Bull (1993) 0.99
Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants. Biochem J (2001) 0.95
Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharm Res (2001) 0.91
Controlled-release preparation of indomethacin using calcium alginate gel. Biol Pharm Bull (1993) 0.91
Nanomolar quantification and identification of various nitrosothiols by high performance liquid chromatography coupled with flow reactors of metals and Griess reagent. J Biochem (1997) 0.90
Study of interaction of carprofen and its enantiomers with human serum albumin--II. Stereoselective site-to-site displacement of carprofen by ibuprofen. Biochem Pharmacol (1993) 0.88
Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety. Biochim Biophys Acta (1999) 0.88
Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group. Biochem Pharmacol (1993) 0.88
Effect of oxidative stress on the structure and function of human serum albumin. Pharm Res (2001) 0.87
Purification and characterization of L-2,3-butanediol dehydrogenase of Brevibacterium saccharolyticum C-1012 expressed in Escherichia coli. Biosci Biotechnol Biochem (2001) 0.86
In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharm Res (2001) 0.86
Calcium ion binding to clinically relevant chemical modifications of human serum albumin. Clin Chem (1995) 0.85
Characterization of region Ic in site I on human serum albumin. Microenvironmental analysis using fluorescence spectroscopy. Biol Pharm Bull (1994) 0.85
Kinetic analysis of the covalent binding of captopril to human serum albumin. J Pharm Sci (1997) 0.84
[Stabilization and reduction of irritant taste of anti-inflammatory drug pirprofen by beta-cyclodextrin complexation]. Yakugaku Zasshi (1984) 0.84
Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation. J Pharm Sci (1983) 0.84
Inclusion complexes of beta-cyclodextrin with tranquilizing drugs phenothiazines in aqueous solution. Chem Pharm Bull (Tokyo) (1975) 0.83
Alleviation of prochlorperazine-induced primary irritation of skin by cyclodextrin complexation. Chem Pharm Bull (Tokyo) (1982) 0.83
Conjugation of Cu,Zn-superoxide dismutase with succinylated gelatin: pharmacological activity and cell-lubricating function. Bioconjug Chem (1994) 0.83
Preparation and evaluation of a controlled-release formulation of nifedipine using alginate gel beads. Biol Pharm Bull (1993) 0.83
Charcoal hemoperfusion in the treatment of phenytoin overdose. Am J Kidney Dis (2000) 0.83
A comparative study of the interaction of warfarin with human alpha 1-acid glycoprotein and human albumin. J Pharm Pharmacol (1987) 0.82
Stereospecific activity and nature of metabolizing esterases for propranolol prodrug in hairless mouse skin, liver and plasma. Life Sci (1997) 0.82
Cytotoxicity of absorption enhancers in Caco-2 cell monolayers. J Pharm Pharmacol (1998) 0.82
Interactive binding to the two principal ligand binding sites of human serum albumin: effect of the neutral-to-base transition. Biochim Biophys Acta (1999) 0.82
Study of interaction of carprofen and its enantiomers with human serum albumin--I. Mechanism of binding studied by dialysis and spectroscopic methods. Biochem Pharmacol (1993) 0.82
Species differences of serum albumins: II. Chemical and thermal stability. Pharm Res (1998) 0.82
Genogroup distribution of F-specific coliphages in wastewater and river water in the Kofu basin in Japan. Lett Appl Microbiol (2012) 0.81
Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug. Chem Pharm Bull (Tokyo) (1999) 0.81
Evaluation of stereoselective transdermal transport and concurrent cutaneous hydrolysis of several ester prodrugs of propranolol: mechanism of stereoselective permeation. Pharm Res (1996) 0.80
Reduction of erythrocyte membrane permeability and protein binding of low-molecular-weight drugs following glycoside derivitization. J Pharm Sci (1993) 0.80
Mechanism of stereoselective serum binding of ketoprofen after hemodialysis. J Pharmacol Exp Ther (1996) 0.80
Effects of penicillins on binding of phenytoin to plasma proteins in vitro and in vivo. Biopharm Drug Dispos (1984) 0.80
Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen. AAPS PharmSciTech (2000) 0.80
Inclusion complexation of doxorubicin and daunorubicin with cyclodextrins. J Pharm Biomed Anal (1990) 0.79
Effects of absorption enhancers on cytoskeletal actin filaments in Caco-2 cell monolayers. Life Sci (1998) 0.79
Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses. J Pharm Pharmacol (1981) 0.79
Characterization of drug binding sites on alpha 1-acid glycoprotein. Chem Pharm Bull (Tokyo) (1990) 0.78
Purification and properties of carbonyl reductase from rabbit kidney. Arch Biochem Biophys (1993) 0.78
Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution. Acta Pharm Suec (1984) 0.78
An immunological method for the detection of captopril-protein conjugate. Arch Toxicol (1998) 0.78
Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin. Pharm Res (1999) 0.78
In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs. Pharm Res (1999) 0.78
Interactions of aldosterone antagonist diuretics with human serum proteins. Pharm Res (1997) 0.78
Effects of fatty acids on serum binding between furosemide and valproic acid. Biol Pharm Bull (1998) 0.78
Effect of cyclodextrins on anthracycline stability in acidic aqueous media. Pharm Weekbl Sci (1988) 0.78
Purification and catalytic properties of a tetrameric carbonyl reductase from rabbit heart. J Biochem (1999) 0.78
Evaluation of quinaldine red as a fluorescent probe for studies of drug-alpha 1-acid glycoprotein interaction. Biol Pharm Bull (1993) 0.78
Enhancement of the dissolution rates of poorly water-soluble drugs by water-soluble gelatin. Chem Pharm Bull (Tokyo) (1989) 0.78
Effects of repeated clarithromycin administration on the pharmacokinetic properties of pindolol in rats. Biol Pharm Bull (1998) 0.77
Enhanced bioavailability of digoxin by gamma-cyclodextrin complexation. J Pharmacobiodyn (1981) 0.77
Up-regulation by clarithromycin of alpha(1)-acid glycoprotein expression in liver and primary cultured hepatocytes. Biochem Pharmacol (2001) 0.77
Improvement in percutaneous absorption of prednisolone by beta- and gamma-cyclodextrin complexations. Chem Pharm Bull (Tokyo) (1987) 0.77
Postnatal development, sex-related difference and hormonal regulation of acetohexamide reductase activities in rat liver and kidney. J Pharmacol Exp Ther (1993) 0.77
An in-vitro and in-vivo correlative approach to the evaluation of ester prodrugs to improve oral delivery of propranolol. J Pharm Pharmacol (1993) 0.77
Inclusion complexes of beta-cyclodextrin with antiinflammatory drugs fenamates in aqueous solution. Chem Pharm Bull (Tokyo) (1975) 0.77
Further characterization of reversal of signs of induced cotton effects of dicumarol derivatives-alpha 1-acid glycoprotein systems by protriptyline. Biochem Pharmacol (1992) 0.77
Study of interaction of pranoprofen with human serum albumin: binding properties of enantiomers and metabolite. J Pharmacobiodyn (1992) 0.77
Influence of streptozocin-induced diabetes on reductive metabolism of acetohexamide in rat liver. J Pharm Pharmacol (1989) 0.77
Effect of pH and small inorganic ions on binding of sulfadimethoxine and sulfaphenazole to human serum albumin measured by circular dichroism. Chem Pharm Bull (Tokyo) (1989) 0.77
Mode of interaction of loop diuretics with human serum albumin and characterization of binding site. Pharm Res (1996) 0.77
Stereoselective disposition of flurbiprofen from a mutual prodrug with a histamine H2-antagonist to reduce gastrointestinal lesions in the rat. Chirality (1996) 0.77
Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state. J Pharm Pharmacol (1993) 0.77
Species differences of serum albumins: III. Analysis of structural characteristics and ligand binding properties during N-B transitions. Pharm Res (1998) 0.77
Covalent binding of a bucillamine derivative with albumin in sera from healthy subjects and patients with various diseases. Pharm Res (1997) 0.77
Comparative study of interaction mode of diazepines with human serum albumin and alpha 1-acid glycoprotein. J Pharm Sci (1992) 0.77
Alteration of pharmacokinetics and nephrotoxicity of cisplatin by alginates. J Pharm Sci (1997) 0.77
Reversal of signs of induced cotton effects of dicumarol-alpha 1-acid glycoprotein systems by phenothiazine neuroleptics through ternary complexation. Pharm Res (1992) 0.76
Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid. Nephron (2000) 0.76
20beta-hydroxysteroid dehydrogenase catalyzes ketone-reduction of acetohexamide, an oral antidiabetic drug, in liver microsomes of adult male rats. J Pharmacol Exp Ther (1998) 0.76
Protective effects of cyclodextrins on drug-induced hemolysis in vitro. J Pharmacobiodyn (1981) 0.76
Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers. J Pharm Pharmacol (1999) 0.76
Covalent binding between bucillamine derivatives and human serum albumin. Pharm Res (1996) 0.76
Investigation of the interaction mode of phenothiazine neuroleptics with alpha 1-acid glycoprotein. J Pharm Pharmacol (1992) 0.76
Kinetic studies on the reduction of acetohexamide catalyzed by carbonyl reductase from rabbit kidney. Biochim Biophys Acta (1993) 0.76
Study on the binding of dicumarol to alpha 1-acid glycoprotein using circular dichroism spectroscopy. Chem Pharm Bull (Tokyo) (1988) 0.76
Flunitrazepam, a 7-nitro-1,4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin. Biochim Biophys Acta (2001) 0.76
[Inclusion complexation of p-hydroxybenzoic acid esters with alpha- and beta-cyclodextrins: dissolution behaviors and antimicrobial activities (author's transl)]. Yakugaku Zasshi (1980) 0.76
Urinary metabolites of 2,6-diisopropylnaphthalene in rats. Drug Metab Dispos (1982) 0.75